Indian stocks: Visit www.stage2stocks.com →

Medpace Holdings, Inc.

Stage 2 · Advancing · week 11

As of Oct 22, 2026, Medpace Holdings is in Stage 2, the uptrend phase, now in week 11 (since Aug 7, 2026). It closed at $653.96, at its 52-week high and above its 200-day average, which is rising.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. More about the company

$653.96
+0.15% today
$18.3B · Large cap
Market Neutral — Fading

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 32 in Diagnostics & Research · #1 of 272 in Health Care

Is MEDP early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 27w
S4 16w
S4 17w
S2 28w
S4 14w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 8w → S3 5w → S2 27w → S3 5w → S2 6w → S3 6w → S4 16w → S1 6w → S4 17w → S1 4w → S2 28w → S3 7w → S4 14w → S1 4w → S2 11w current
Total tracked: 165 weeks across 15 stage runs.

MEDP among Diagnostics & Research22nd of 44 by relative strength

All 44 →
Stocks in Diagnostics & Research ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CDNAStage 2 · wk 2499+27.3%
2BDSXStage 2 · wk 1898−18.3%
3ILMNStage 2 · wk 2497+5.5%
4GHStage 2 · wk 2197−7.6%
5NTRAStage 2 · wk 2096+2.7%
6CRLStage 2 · wk 1692+22.5%
7RVTYStage 2 · wk 1890+10.7%
8PSNLStage 2 · wk 1790−3.2%
…22MEDPStage 2 · wk 1170+6.0%
vs 52W High
0.0%
$393.42 lo$653.96 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 11
1w13w26w
Week 11, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
24.0%
200 DMA: $527.28 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
3.59x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+6.0%
3M
+8.7%
6M
+66.2%
YTD
+14.5%
1Y
+19.9%
Scan Membership
Breakout Watch
Latest: 2024-07-01
11 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 11 · Vol 3.59x
2026-10-21S2
Wk 11 · Vol 3.48x
2026-10-20S2
Wk 11 · Vol 1.74x
2026-10-19S2
Wk 11 · Vol 1.07x
2026-10-16S2
Wk 10 · Vol 1.44x
2026-10-15S2
Wk 10 · Vol 1.75x
2026-10-14S2
Wk 10 · Vol 1.40x
2026-10-13S2
Wk 10 · Vol 0.69x
2026-10-12S2
Wk 10 · Vol 0.78x
2026-10-09S2
Wk 9 · Vol 0.70x
2026-10-08S2
Wk 9 · Vol 0.95x
2026-10-07S2
Wk 9 · Vol 0.84x
Moving averages & range
50 DMA
$609.47
200 DMA
$527.28
52W High
$653.96
52W Low
$393.42
5D Low
$618.47
Resistance levels (recent highs)
20d High
$653.96
60d High
$653.96
120d High
$653.96
250d High
$653.96
Next resistance
Above all
P/E (TTM)
36.3
Forward 33.8
Earnings Growth (YoY)
+37.1%
Revenue +17.2%
ROE
+162.2%
Profit margin +17.7%
Dividend Yield
0.00%
P/B 40.4

Medpace Holdings: quick answers

What stage is Medpace Holdings in?

As of Oct 22, 2026, Medpace Holdings (MEDP) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 7, 2026 and is in week 11. What the four stages mean

Is Medpace Holdings in an uptrend?

Yes. Medpace Holdings is in a Stage 2 uptrend. It trades 24.0% above its 200-day average, which is rising.

How far is Medpace Holdings from its 52-week high?

Medpace Holdings closed at $653.96 on Oct 22, 2026, at its 52-week high. Its 52-week low is $393.42.

How has Medpace Holdings performed over the past year?

As of Oct 22, 2026, Medpace Holdings is up 19.9% over the past year and up 14.5% so far in 2026.

Which sector and industry is Medpace Holdings in?

Medpace Holdings is in the Diagnostics & Research industry, part of the Health Care sector.

About this companyHealth Care· Diagnostics & Research

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.